Financials data is unavailable for this security.
View more
Year on year Dexcom Inc grew revenues 24.49% from 2.91bn to 3.62bn while net income improved 58.70% from 341.20m to 541.50m.
Gross margin | 62.10% |
---|---|
Net profit margin | 17.22% |
Operating margin | 15.88% |
Return on assets | 10.51% |
---|---|
Return on equity | 32.06% |
Return on investment | 14.28% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at Dexcom Inc fell by 75.80m. However, the company earned 748.50m from its operations for a Cash Flow Margin of 20.66%. In addition the company used 507.20m on investing activities and also paid 318.60m in financing cash flows.
Cash flow per share | 2.15 |
---|---|
Price/Cash flow per share | 32.51 |
Book value per share | 5.07 |
---|---|
Tangible book value per share | 4.73 |
More ▼
Balance sheet in USDView more
Current ratio | 2.46 |
---|---|
Quick ratio | 2.12 |
Total debt/total equity | 1.26 |
---|---|
Total debt/total capital | 0.5579 |
More ▼
Growth rates in USD
Year on year, growth in earnings per share excluding extraordinary items increased 59.45%.
EPS growth(5 years) | -- |
---|---|
EPS (TTM) vs TTM 1 year ago | 85.53 |